carmustine
ItalyDrugs containing this active substance
-
This medicine contains carmustine, an anticancer substance that slows the growth of tumor cells. It is used to treat several types of tumors, including brain tumors, multiple myeloma, Hodgkin's disease, non-Hodgkin lymphomas, gastrointestinal tract tumors, and malignant melanoma. It is also used as a preparation before a stem cell transplant.
Form: powder and solvent for concentrate for solution for infusion
Active substance Dosage carmustine - ATC: L01AD01
Manufacturer: TILLOMED ITALIA SRL
-
This medicinal product is an antineoplastic agent used to treat several types of tumors, including brain tumors, multiple myeloma, Hodgkin's disease, non-Hodgkin lymphomas, and certain gastrointestinal tract tumors. It is also used as a preparation before a stem cell transplant.
Form: powder and solvent for concentrate for solution for infusion
Active substance Dosage carmustine - ATC: L01AD01
Manufacturer: Eugia Pharma (Malta) Limited
-
It is an antitumoral drug used in adults to treat various types of tumors, including brain tumors, lymphomas (Hodgkin and non-Hodgkin), gastrointestinal tract tumors, malignant melanoma, and as preparation before a stem cell transplant in certain blood diseases.
Form: solution for infusion, powder and solvent for preparation
Active substance Dosage carmustine - ATC: L01AD01
Manufacturer: MEDAC GESELLSCHAFT FUR KLINISCHE SPEZIALPRAPARATE MBH
-
This drug is an antineoplastic agent used to treat several types of malignant tumors, including brain tumors (such as glioblastoma and astrocytoma), brain metastases, lymphomas (Hodgkin and non-Hodgkin), multiple myeloma, and as preparation for stem cell transplantation in certain blood diseases.
Form: powder and solvent for concentrate for solution for infusion
Active substance Dosage carmustine - ATC: L01AD01
Manufacturer: WAYMADE B.V.
-
It is used to treat adult patients with brain tumors (such as high-grade glioma or glioblastoma multiforme) as an adjunct to surgery and radiotherapy, helping to combat the proliferation of tumor cells and prolonging survival.
Form: implant
Active substance Dosage carmustine - ATC: L01AD01
Manufacturer: CLINIGEN HEALTHCARE B.V.